100 Recruiting Studies Using Etoposide
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Etoposide
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
π Children's Hospital of Alabama β Birmingham, Alabama
Acute Lymphoblastic Leukemia
View Study & Checklist βA Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer
π Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital β Marietta, Georgia
Small-Cell Lung Cancer
View Study & Checklist βRisk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy
π University of Florida Proton Therapy Institute β Jacksonville, Florida
Rhabdomyosarcoma
View Study & Checklist βPlacebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-NaΓ―ve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)
π Ironwood Cancer & Research Centers ( Site 0007) β Chandler, Arizona
Small Cell Lung Cancer
View Study & Checklist βTesting the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)
π University of Alabama at Birmingham Cancer Center β Birmingham, Alabama
Limited Stage Lung Small Cell Carcinoma
View Study & Checklist βAdcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma
π Lucile Packard Children's Hospital Stanford University β Palo Alto, California
Stage II Childhood Hodgkin Lymphoma
View Study & Checklist βA Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia
π Children's Hospital of Central California β Madera, California
Acute Myeloid Leukemia
View Study & Checklist βCombination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
π University of Alabama at Birmingham Cancer Center β Birmingham, Alabama
Acute Lymphoblastic Leukemia
View Study & Checklist βTesting the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas
π University of Alabama at Birmingham Cancer Center β Birmingham, Alabama
Diffuse Large B-Cell Lymphoma
View Study & Checklist βCombination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma
π Children's Hospital of Alabama β Birmingham, Alabama
Adult T Acute Lymphoblastic Leukemia
View Study & Checklist βPhase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)
π Research Site β Duarte, California
Non-Small Cell Lung Cancer
View Study & Checklist βHuman Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
π City of Hope Medical Center β Duarte, California
Allogeneic Hematopoietic Stem Cell Transplant Recipient
View Study & Checklist βChemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia
π Fred Hutch/University of Washington Cancer Consortium β Seattle, Washington
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
View Study & Checklist β2015-12: A Study Exploring the Use of Early and Late Consolidation/Maintenance Therapy
π University of Arkansas for Medical Sciences β Little Rock, Arkansas
Multiple Myeloma
View Study & Checklist βNovel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma
π Arthur J.E. Child Comprehensive Cancer Centre β Calgary, Alberta
Lymphoma
View Study & Checklist βIbrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
π Anchorage Associates in Radiation Medicine β Anchorage, Alaska
Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type
View Study & Checklist βA Study of N9 Chemotherapy in Children With Neuroblastoma
π Memorial Sloan Kettering Cancer Center β New York, New York
Neuroblastoma
View Study & Checklist βCisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas
π Kingman Regional Medical Center β Kingman, Arizona
Gastric Neuroendocrine Carcinoma
View Study & Checklist βDAREONβ’-7: A Study to Test How Well Different Doses of BI 764532 in Addition to Chemotherapy Are Tolerated by People With Advanced Neuroendocrine Cancers
π University of Miami β Miami, Florida
Neuroendocrine Neoplasms
View Study & Checklist βCombination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma
π Anchorage Associates in Radiation Medicine β Anchorage, Alaska
Lymphoma
View Study & Checklist βResponse and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
π Children's Hospital of Alabama β Birmingham, Alabama
Ganglioneuroblastoma
View Study & Checklist βSafety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)
π Children's Hospital of Alabama ( Site 0023) β Birmingham, Alabama
Hodgkin Lymphoma
View Study & Checklist βGene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant
π UC San Diego Moores Cancer Center β La Jolla, California
HIV Infection
View Study & Checklist βStudy of AZD2811 + Durvalumab in ES-SCLC
π Research Site β Grand Rapids, Michigan
Small-Cell Lung Cancer
View Study & Checklist βTrial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy
π University of Arkansas for Medical Sciences β Little Rock, Arkansas
Myeloma
View Study & Checklist βNivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma
π Ohio State University Comprehensive Cancer Center β Columbus, Ohio
Aggressive Non-Hodgkin Lymphoma
View Study & Checklist βLB-100, Carboplatin, Etoposide, and Atezolizumab for the Treatment of Untreated Extensive-Stage Small Cell Lung Cancer
π City of Hope Medical Center β Duarte, California
Extensive Stage Lung Small Cell Carcinoma
View Study & Checklist βUse Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis
π Phoenix Children's Hospital β Phoenix, Arizona
Hemophagocytic Lymphohistiocytosis
View Study & Checklist βPembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008/KEYVIBE-008)
π Infirmary Cancer Care ( Site 0022) β Mobile, Alabama
Small Cell Lung Carcinoma
View Study & Checklist βSafety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood
π Loma Linda University Cancer Center β Loma Linda, California
Acute Myeloid Leukemia
View Study & Checklist βVenetoclax Plus R-ICE Chemotherapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
π Washington University School of Medicine, Siteman Cancer Center β St Louis, Missouri
Diffuse Large B-cell-lymphoma
View Study & Checklist βOlaparib and Durvalumab With Carboplatin, Etoposide, and/or Radiation Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer, PRIO Trial
π M D Anderson Cancer Center β Houston, Texas
Extensive Stage Lung Small Cell Carcinoma
View Study & Checklist βStudy to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma
π University of Alabama Hospital β Birmingham, Alabama
High-risk Large B-cell Lymphoma (LBCL)
View Study & Checklist βDurvalumab Β± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN)
π Research Site β Birmingham, Alabama
Small Cell Lung Carcinoma Extensive Disease
View Study & Checklist βA Study of the Combination of Osimertinib, Platinum and Etoposide for Patients With Metastatic EGFR Mutant Lung Cancers
π Memorial Sloan Kettering Cancer Center β Basking Ridge, New Jersey
Lung Cancer
View Study & Checklist βNivolumab, Ifosfamide, Carboplatin, and Etoposide as Second-Line Therapy in Treating Patients With Refractory or Relapsed HL
π City of Hope Medical Center β Duarte, California
Recurrent Hodgkin Lymphoma
View Study & Checklist βA Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab
π AdventHealth β Orlando, Florida
Extensive Stage Small Cell Lung Cancer
View Study & Checklist βPhase 2 Study of Alisertib Therapy for Rhabdoid Tumors
π Lucille Packard Children's Hospital at Stanford University Medical Center β Palo Alto, California
Malignant Rhabdoid Tumor
View Study & Checklist βFirst-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC)
π University of Southern California, Norris Comprehensive Cancer Center β Los Angeles, California
Extensive Stage Small Cell Lung Cancer
View Study & Checklist βBlinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
π Children's Hospital of Alabama β Birmingham, Alabama
Recurrent B Acute Lymphoblastic Leukemia
View Study & Checklist βLoncastuximab Tesirine in Combination With DA-EPOCH-R in Patients With Previously Untreated Aggressive B-cell Lymphoid Malignancies
π University of Texas Southwestern β Dallas, Texas
B-cell Lymphoma
View Study & Checklist βComparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer
π University of Florida Health Science Center - Jacksonville β Jacksonville, Florida
Stage II Non-Small Cell Lung Cancer AJCC v7
View Study & Checklist βIrinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma
π Memorial Sloan Kettering Cancer Center β New York, New York
Sarcoma
View Study & Checklist βPolatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphoma
π Fred Hutch/University of Washington Cancer Consortium β Seattle, Washington
Aggressive Non-Hodgkin Lymphoma
View Study & Checklist βPharmacogenomics ANDA SNP Clinical Study - Etoposide and Single Nucleotide Polymorphisms
π Medicine Invention Design, Inc. (MIDI) - IORG0007849 - NPI 1023387701 β Rockville, Maryland
Small Cell Lung Cancer
View Study & Checklist βTafasitamab and Lenalidomide Followed by Tafasitamab and ICE as Salvage Therapy for Transplant Eligible Patients With Relapsed/ Refractory Large B-Cell Lymphoma
π Ohio State University Comprehensive Cancer Center β Columbus, Ohio
Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma
View Study & Checklist βChemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment NaΓ―ve Patients With Extensive Stage Small Cell Lung Cancer
π University of Illinois Medical Center β Chicago, Illinois
Extensive Stage Small Cell Lung Cancer
View Study & Checklist βTreatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents
π Boston Children's Hospital β Boston, Massachusetts
Acute Lymphoblastic Leukemia, Pediatric
View Study & Checklist βA Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin Lymphoma
π Hospital Aleman β Ciudad Autonoma de Buenos Aires, Buenos Aires
B-Cell Non-Hodgkin Lymphoma (B-NHL)
View Study & Checklist βConcurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell Lymphoma
π MD Anderson Cancer Center β Houston, Texas
Lymphoma
View Study & Checklist βPolatuzumab Vedotin, Rituximab, Ifosfamide, Carboplatin, and Etoposide (PolaR-ICE) as Initial Salvage Therapy for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
π City of Hope Medical Center β Duarte, California
Diffuse Large B-Cell Lymphoma Unclassifiable
View Study & Checklist βPembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate
π UCLA / Jonsson Comprehensive Cancer Center β Los Angeles, California
Bladder Small Cell Neuroendocrine Carcinoma
View Study & Checklist βSafety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 Mutation
π City of Hope β Duarte, California
Newly Diagnosed Acute Myeloid Leukemia (AML)
View Study & Checklist βCisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery
π Children's Hospital of Alabama β Birmingham, Alabama
Childhood Hepatocellular Carcinoma
View Study & Checklist βPaclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors
π University of Southern California β Los Angeles, California
Germ Cell Tumors
View Study & Checklist βProtocol for the Study and Treatment of Participants With Intraocular Retinoblastoma
π St. Jude Children's Research Hospital β Memphis, Tennessee
Retinoblastoma
View Study & Checklist βNivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma
π Children's Hospital of Alabama β Birmingham, Alabama
Primary Mediastinal Large B-Cell Lymphoma
View Study & Checklist βAutologous Stem Cell Transplant for Neurologic Autoimmune Diseases
π Colorado Blood Cancer Institute β Denver, Colorado
Autoimmune Disease
View Study & Checklist βTotal Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma
π Lucile Packard Children's Hospital Stanford University β Palo Alto, California
Acute Lymphoblastic Leukemia
View Study & Checklist βA Phase III, Randomised Study of Adjuvant Dato-DXd in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Standard of Care, Following Complete Tumour Resection, in Participants With Stage I Adenocarcinoma NSCLC Who Are ctDNA-positive or Have High-risk Pathological Features
π Research Site β Tucson, Arizona
Non-small Cell Lung Cancer
View Study & Checklist βTesting the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer
π Anchorage Associates in Radiation Medicine β Anchorage, Alaska
Recurrent Lung Non-Small Cell Carcinoma
View Study & Checklist βTesting a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body
π Children's Hospital of Alabama β Birmingham, Alabama
CIC-Rearranged Sarcoma
View Study & Checklist βCarfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell Lymphoma
π Roswell Park Cancer Institute β Buffalo, New York
CD20 Positive
View Study & Checklist βBrentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma
π City of Hope Comprehensive Cancer Center β Duarte, California
Adult T-Cell Leukemia/Lymphoma
View Study & Checklist βUARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete Remission
π University of Arkansas for Medical Sciences β Little Rock, Arkansas
Multiple Myeloma
View Study & Checklist βLenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma
π National Institutes of Health Clinical Center β Bethesda, Maryland
Primary Effusion Lymphoma
View Study & Checklist βStudy of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)
π University of South Alabama, Mitchell Cancer Institute ( Site 0003) β Mobile, Alabama
Lung Neoplasms
View Study & Checklist βCombination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma
π Children's Hospital of Alabama β Birmingham, Alabama
Metastatic Ewing Sarcoma
View Study & Checklist βSafety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy
π Alaska Oncology and Hematology, LLC β Anchorage, Alaska
Extensive-stage Small-cell Lung Cancer
View Study & Checklist βBrentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma
π Children's Hospital of Alabama β Birmingham, Alabama
Ann Arbor Stage IIB Hodgkin Lymphoma
View Study & Checklist βIrinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma
π Memorial Sloan Kettering Cancer Center Basking Ridge β Basking Ridge, New Jersey
Newly Diagnosed Ewing Sarcoma
View Study & Checklist βTesting the Addition of an Anti-cancer Drug, M3814, to the Usual Treatment (Mitoxantrone, Etoposide, and Cytarabine) for Relapsed or Refractory Acute Myeloid Leukemia
π City of Hope Comprehensive Cancer Center β Duarte, California
Recurrent Acute Myeloid Leukemia
View Study & Checklist βPediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG
π Augusta University, Georgia Cancer Center β Augusta, Georgia
Glioblastoma
View Study & Checklist βCombination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
π Banner University Medical Center - Tucson β Tucson, Arizona
Acute Lymphoblastic Leukemia
View Study & Checklist βUse of High Dose Radiation Followed by Chemotherapy and Radiation to Treat Locally Advanced NSCLC
π Levine Cancer Institute β Charlotte, North Carolina
Lung Cancer Stage II
View Study & Checklist βTotal Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I
π Children's Hospital Los Angeles β Los Angeles, California
Acute Lymphoblastic Leukemia
View Study & Checklist βCellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic Leukemia
π City of Hope Comprehensive Cancer Center β Duarte, California
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma
View Study & Checklist βUARK 2006-66, Total Therapy 3B: An Extension of UARK 2003-33 Total Therapy
π University of Arkansas for Medical Sciences/Myeloma Institute β Little Rock, Arkansas
Multiple Myeloma
View Study & Checklist βPediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17
π Lucile Packard Children's Hospital Stanford University β Palo Alto, California
Hodgkin Lymphoma
View Study & Checklist βSirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors
π Phoenix Children's Hospital β Phoenix, Arizona
Cancer
View Study & Checklist βGene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma
π NCI Lymphoid Malignancies Branch β Bethesda, Maryland
AIDS-Related Burkitt Lymphoma
View Study & Checklist βTrial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax
π Memorial Sloan Kettering Cancer Center β New York, New York
Refractory Acute Lymphoblastic Leukemia
View Study & Checklist βIbrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas
π UC San Diego Moores Cancer Center β La Jolla, California
AIDS-Related Lymphoma
View Study & Checklist βStandard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors
π Children's Hospital of Alabama β Birmingham, Alabama
Germ Cell Tumor
View Study & Checklist βStudy of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC
π Research Facility β Los Angeles, California
SCLC,Extensive Stage
View Study & Checklist βCombination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
π Providence Hospital β Mobile, Alabama
Lung Adenocarcinoma
View Study & Checklist βResponse-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome
π Children's Hospital of Alabama β Birmingham, Alabama
Acute Myeloid Leukemia
View Study & Checklist βVirotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity
π National Institutes of Health Clinical Center β Bethesda, Maryland
Lymphoproliferative Disorder
View Study & Checklist βTotal Marrow and Lymphoid Irradiation and Chemotherapy Before DSCT in Treating Patients With High-Risk ALL or AML
π City of Hope Medical Center β Duarte, California
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
View Study & Checklist βDAREONα΅α΄Ή-8: A Study to Test How Well Different Doses of BI 764532 in Addition to Standard of Care Are Tolerated by People With Advanced Small Cell Lung Cancer
π Orlando Health Cancer Institute β Orlando, Florida
Small Cell Lung Carcinoma (SCLC)
View Study & Checklist βHigh Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma
π Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) β Basking Ridge, New Jersey
Non-Hodgkin's Lymphoma
View Study & Checklist βEpcoritamab in Combination With Dose Adjusted EPOCH-R for High-risk Burkitt Lymphoma (BL), The BEDROCK Study
π Memorial Sloan Kettering Cancer Center β New York, New York
Adult Burkitt Lymphoma
View Study & Checklist βFUS Etoposide for DMG
π Columbia University Irving Medical Center β New York, New York
Diffuse Intrinsic Pontine Glioma
View Study & Checklist βLamivudine in Combination With Chemoimmunotherapy for the Treatment of Extensive Stage Small Cell Lung Cancer
π Roswell Park Cancer Institute β Buffalo, New York
Extensive Stage Lung Small Cell Carcinoma
View Study & Checklist βN10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma
π Memorial Sloan Kettering Cancer Center β New York, New York
High-risk Neuroblastoma
View Study & Checklist βAtezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
π Johns Hopkins University: Sibley Memorial Hospital β Washington D.C., District of Columbia
Small Cell Neuroendocrine Carcinoma of Bladder
View Study & Checklist βA Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
π Children's Hospital of Alabama β Birmingham, Alabama
Anaplastic Kidney Wilms Tumor
View Study & Checklist βSirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors
π Aflac Cancer & Blood Disorders Centers β Atlanta, Georgia
Solid Tumor
View Study & Checklist βUPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AML
π Texas Children's Cancer and Hematology Center β Houston, Texas
Acute Myeloid Leukemia
View Study & Checklist βTesting the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplatin and Etoposide or Carboplatin and Paclitaxel) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma
π Los Angeles General Medical Center β Los Angeles, California
Advanced NUT Carcinoma
View Study & Checklist β